Chen Timothy Yung-Cheng 4

Accession 0001651308-20-000121

CIK 0001651308other

View on SEC.gov Company Profile

Filed

Aug 11, 8:00 PM ET

Accepted

Aug 12, 5:02 PM ET

Size

31.4 KB

Accession

0001651308-20-000121

Insider Transaction Report

Form 4

Period: 2020-08-10

BeiGene, Ltd.BGNE

Chen Timothy Yung-Cheng

Director

Transactions

Sale
American Depositary Shares
2020-08-10$212.34/sh−700$148,641→ 1,500 total
Exercise/Conversion
Share Option (Right to Buy)
2020-08-10−28,600→ 329,326 total
Exercise: $2.43Exp: 2026-02-08→ Ordinary Shares (28,600 underlying)
Sale
American Depositary Shares
2020-08-10$213.25/sh−400$85,301→ 1,100 total
Exercise/Conversion
American Depositary Shares
2020-08-10$31.59/sh+2,200$69,498→ 2,200 total
Sale
American Depositary Shares
2020-08-10$214.66/sh−500$107,332→ 600 total
Sale
American Depositary Shares
2020-08-10$215.47/sh−300$64,641→ 300 total
Sale
American Depositary Shares
2020-08-10$216.57/sh−300$64,971→ 0 total
Exercise/Conversion
American Depositary Shares
2020-08-11$31.59/sh+1,903$60,116→ 1,903 total
Sale
American Depositary Shares
2020-08-11$212.41/sh−1,000$212,407→ 903 total
Sale
American Depositary Shares
2020-08-11$213.59/sh−700$149,513→ 203 total
Sale
American Depositary Shares
2020-08-11$214.23/sh−203$43,489→ 0 total
Exercise/Conversion
American Depositary Shares
2020-08-12$31.59/sh+2,897$91,516→ 2,897 total
Sale
American Depositary Shares
2020-08-12$212.00/sh−2,897$614,165→ 0 total
Exercise/Conversion
Share Option (Right to Buy)
2020-08-11−24,739→ 304,587 total
Exercise: $2.43Exp: 2026-02-08→ Ordinary Shares (24,739 underlying)
Exercise/Conversion
Share Option (Right to Buy)
2020-08-12−37,661→ 266,926 total
Exercise: $2.43Exp: 2026-02-08→ Ordinary Shares (37,661 underlying)

Footnotes (12)

[F1]Each American Depositary Share represents 13 Ordinary Shares.
[F10]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $212.00 to $212.01, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
[F11]The number of securities underlying each option and the exercise price therefor are represented in ordinary shares.
[F12]These securities vest over a three-year period as follows: 1/3 of these securities become exercisable on each anniversary of February 8, 2016.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $212.00 to $212.99, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
[F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $213.00 to $213.61, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
[F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $214.25 to $215.23, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
[F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $215.35 to $215.53, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares sold at each separate price.
[F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $216.44 to $216.74, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
[F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $212.03 to $213.01, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
[F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $213.09 to $213.93, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
[F9]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $214.16 to $214.30, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Documents

1 file

4
wf-form4_159726614534101.xmlPrimary
FORM 4

Issuer

BeiGene, Ltd.

CIK 0001651308

→

Entity typeother

Related Parties

filerCIK 0001374068

Filing Metadata

Form type: 4
Filed: Aug 11, 8:00 PM ET
Accepted: Aug 12, 5:02 PM ET
Size: 31.4 KB

View on SEC.gov